0001824893-24-000002.txt : 20240419 0001824893-24-000002.hdr.sgml : 20240419 20240419153826 ACCESSION NUMBER: 0001824893-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240419 DATE AS OF CHANGE: 20240419 EFFECTIVENESS DATE: 20240419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Surrozen, Inc./DE CENTRAL INDEX KEY: 0001824893 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 301374889 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-511096 FILM NUMBER: 24857503 BUSINESS ADDRESS: STREET 1: 171 OYSTER POINT BLVD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-475-2820 MAIL ADDRESS: STREET 1: 171 OYSTER POINT BLVD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Consonance-HFW Acquisition Corp. DATE OF NAME CHANGE: 20200915 D 1 primary_doc.xml X0708 D LIVE 0001824893 Surrozen, Inc./DE 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650-475-2820 DELAWARE Consonance-HFW Acquisition Corp. Corporation true 2021 Craig Parker 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Charles Williams 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Executive Officer David J. Woodhouse, Ph.D. 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Anna Berkenblit, M.D. 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Eric Bjerkholt 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Christopher Chai 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Mary Haak-Frendscho, Ph.D. 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Tim Kutzkey, Ph.D. 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Shao-Lee Lin, M.D., Ph.D. 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Mace Rothenberg, M.D. 171 Oyster Point Blvd, Suite 400 South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2024-04-04 false true true true false 0 Guggenheim Securities, LLC 40638 None None 330 Madison Avenue New York NY NEW YORK 10017 All States false 193015962 193015962 0 The Total Offering Amount and Total Amount Sold include amounts that may be received by the Issuer upon exercise of the warrants. false 18 0 0 0 false Surrozen, Inc./DE /s/ Charles Williams Charles O. Williams Chief Financial Officer and COO 2024-04-19